Twin Tree Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Twin Tree Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-183,077	Closed	-$20.8M	–	1648
2022 Q4	$20.8M	Buy	+183,077	New	+$15.2M	0.05%	388
2022 Q2	–	Sell	-19,298	Closed	-$2.03M	–	1947
2022 Q1	$2.03M	Buy	+19,298	New	+$1.88M	﹤0.01%	1159
2021 Q4	–	Sell	-104,485	Closed	-$11.4M	–	1920
2021 Q3	$11.4M	Buy	104,485 +31,391	+43%	+$3.26M	0.03%	529
2021 Q2	$6.84M	Buy	73,094 +7,954	+12%	+$732K	0.02%	619
2021 Q1	$6M	Buy	65,140 +21,492	+49%	+$1.81M	0.02%	600
2020 Q4	$3.19M	Buy	43,648 +4,602	+12%	+$342K	0.01%	747
2020 Q3	$3.03M	Sell	39,046 -97,166	-71%	-$6.69M	0.01%	686
2020 Q2	$7.57M	Buy	136,212 +134,336	+7,161%	+$5.75M	0.03%	537
2020 Q1	$56K	Buy	+1,876	New	+$63.5K	﹤0.01%	1143
2019 Q2	–	Sell	-294	Closed	-$8K	–	1684
2019 Q1	$8K	Buy	+294	New	+$6.97K	﹤0.01%	1247

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Twin Tree Management's HZNP Position: Q1 2023 in Review

Twin Tree Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 183,077 shares — an estimated $20.8M sold.

Twin Tree Management first reported a position in HZNP in Q1 2019 and held it in 10 quarters. The position peaked at $20.8M in Q4 2022. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Twin Tree Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Twin Tree Management sold 183,077 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $20.8M.
Twin Tree Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 10 quarters.
Twin Tree Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $20.8M in Q4 2022.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Twin Tree Management's 13F filing for Q1 2023, filed 10 May 2023.